Kras Mutations News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Kras Mutations. Real-time updates on events, politics, business and more.

DESTINY-CRC02: Trastuzumab Deruxtecan in HER2+ Metastatic Colorectal Cancer

July 21, 2023

An overview of the DESTINY-CRC02 study, which looked at trastuzumab deruxtecan in patients with HER2+ metastatic colorectal cancer.

Tanioss Bekaii Saab Colorectal Cancer Metastatic Colorectal Cancer Destiny Crc01 Destiny Crc02 Trastuzumab Deruxtecan

Source: onclive.com

Personalized Medicine Coalition Report Review

March 16, 2023

The PMC released its annual report on the progress of precision medicine as measured by precision medicine FDA approvals in 2022. The report summarizes the improved patient outcomes and urges policymakers to continue to support policies that encourage advancement.

Personalized Medicine Coalition Food And Drug Administration Precision Medicine Personalized Medicine Coalition Gene Based Therapy Kras Mutations

Source: natlawreview.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Kras Mutations News Today

DESTINY-CRC02: Trastuzumab Deruxtecan in HER2+ Metastatic Colorectal Cancer

Personalized Medicine Coalition Report Review

Explore More Categories